LTRN RSI Chart
Last 7 days
-0.6%
Last 30 days
2.2%
Last 90 days
47.8%
Trailing 12 Months
30.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 315.7K | 378.5K | 0 | 765.4K |
2022 | 102.0K | 136.1K | 170.2K | 204.4K |
2021 | 0 | 0 | 0 | 67.9K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 29, 2024 | kreis leslie w. | sold | -8,921 | 4.87 | -1,832 | - |
Feb 29, 2024 | fletcher aaron g.l. | sold | -66,650 | 4.87 | -13,686 | - |
Feb 29, 2024 | kreis leslie w. | sold | -20,380 | 4.87 | -4,185 | - |
Feb 29, 2024 | kreis leslie w. | sold | -66,650 | 4.87 | -13,686 | - |
Feb 29, 2024 | fletcher aaron g.l. | sold | -20,380 | 4.87 | -4,185 | - |
Feb 29, 2024 | fletcher aaron g.l. | sold | -8,921 | 4.87 | -1,832 | - |
Feb 28, 2024 | fletcher aaron g.l. | sold | -76,533 | 4.85 | -15,780 | - |
Feb 28, 2024 | fletcher aaron g.l. | sold | -33,508 | 4.85 | -6,909 | - |
Feb 28, 2024 | fletcher aaron g.l. | sold | -250,299 | 4.85 | -51,608 | - |
Feb 28, 2024 | kreis leslie w. | sold | -250,299 | 4.85 | -51,608 | - |
Which funds bought or sold LTRN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | new | - | 218,873 | 218,873 | -% |
May 15, 2024 | STATE STREET CORP | reduced | -9.73 | 101,679 | 220,458 | -% |
May 15, 2024 | MORGAN STANLEY | added | 19.17 | 3,724 | 6,292 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -21.00 | - | -% |
May 15, 2024 | Stone House Investment Management, LLC | new | - | 1,760 | 1,760 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 188 | 24,551 | 29,533 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -90.7 | - | - | -% |
May 14, 2024 | Qube Research & Technologies Ltd | added | 85,000 | 14,969 | 14,978 | -% |
May 14, 2024 | HORIZON KINETICS ASSET MANAGEMENT LLC | unchanged | - | 130,136 | 253,361 | -% |
May 14, 2024 | CARLSON CAPITAL L P | sold off | -100 | -256,800 | - | -% |
Unveiling Lantern Pharma Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Lantern Pharma Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Lantern Pharma Inc News
Income Statement (Quarterly) | ||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 |
Revenue | 26.1% | 201 | 159 | 118 | 134 | 75.00 | 52.00 | 55.00 | 22.00 | 50.00 | 77.00 | 48.00 |
Operating Expenses | 17.5% | 5,732 | 4,877 | 5,190 | 4,286 | 3,826 | 2,145 | 4,395 | 4,066 | 3,511 | 4,149 | 2,479 |
S&GA Expenses | -100.0% | - | 1,304 | 1,632 | 1,733 | 1,575 | 1,443 | 1,406 | 1,406 | 1,349 | 1,184 | 1,314 |
R&D Expenses | 19.0% | 4,251 | 3,573 | 3,558 | 2,553 | 2,252 | 702 | 2,989 | 2,660 | 2,162 | 2,964 | 1,165 |
Net Income | -30.0% | -5,441 | -4,185 | -4,746 | -3,867 | -3,381 | -2,264 | -4,492 | -4,121 | -3,540 | -4,053 | -2,316 |
Net Income Margin | -9.9% | -22.91* | -20.85* | -37.67* | -44.36* | -69.78* | -84.69* | -119.06* | -137.53* | -182.00* | - | - |
Free Cashflow | 9.4% | -3,070 | -3,390 | -3,591 | -3,766 | -2,675 | -4,044 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Assets | -9.0% | 40.00 | 44.00 | 48.00 | 51.00 | 56.00 | 59.00 | 62.00 | 66.00 | 68.00 | 74.00 | 78.00 | 82.00 | 83.00 | 20.00 | 22.00 | 26.00 | - |
Current Assets | -8.9% | 39.00 | 43.00 | 47.00 | 51.00 | 55.00 | 59.00 | 62.00 | 66.00 | 68.00 | 73.00 | 76.00 | 82.00 | 82.00 | 20.00 | 22.00 | 26.00 | 1.00 |
Cash Equivalents | -16.3% | 18.00 | 22.00 | 26.00 | 28.00 | 32.00 | 37.00 | 39.00 | 43.00 | 47.00 | 52.00 | 55.00 | 61.00 | 81.00 | 19.00 | 21.00 | 24.00 | 1.00 |
Net PPE | -3.5% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 44.9% | 4.00 | 3.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 5.00 | 3.00 | 2.00 | 2.00 | 3.00 | 1.00 | 1.00 | 1.00 | 2.00 | 0.00 |
Current Liabilities | 47.6% | 4.00 | 3.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 5.00 | 3.00 | 2.00 | 2.00 | 3.00 | 1.00 | 1.00 | 1.00 | 2.00 | 0.00 |
Shareholder's Equity | -12.6% | 36.00 | 41.00 | 45.00 | 48.00 | 53.00 | 56.00 | 59.00 | 61.00 | 65.00 | 72.00 | 76.00 | 80.00 | 82.00 | 20.00 | 22.00 | 23.00 | 1.00 |
Retained Earnings | -9.8% | -60.69 | -55.24 | -51.06 | -47.90 | -43.15 | -39.28 | -35.90 | -33.64 | -29.14 | -25.02 | -21.48 | -17.43 | -15.11 | -12.66 | -9.76 | -8.06 | -6.75 |
Additional Paid-In Capital | 0.2% | 96.00 | 96.00 | 97.00 | 96.00 | 96.00 | 96.00 | 95.00 | 95.00 | 95.00 | 97.00 | 97.00 | 97.00 | 97.00 | 32.00 | 31.00 | 31.00 | 8.00 |
Shares Outstanding | 0.4% | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | 11.00 | - | - | - | - | - |
Float | - | - | - | - | 53.00 | - | - | - | 51.00 | - | - | - | 122 | - | - | - | 35.00 | - |
Cashflow (Quarterly) | |||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 |
Cashflow From Operations | 9.4% | -3,068 | -3,385 | -3,612 | -3,591 | -3,757 | -2,668 | -4,038 | -2,732 | -3,327 | -2,039 | -4,682 | -1,725 | -2,144 | -1,568 | -2,889 | -490 | -703 | - | - | - |
Share Based Compensation | -11.2% | 134 | 151 | 191 | 392 | 334 | 330 | 301 | 290 | 267 | 246 | 224 | 246 | 246 | - | - | - | - | - | - | - |
Cashflow From Investing | -317.1% | -556 | 256 | 232 | -457 | -960 | 603 | -74.36 | -525 | 177 | -233 | -1,002 | - | - | -4.99 | -3.32 | - | - | - | - | - |
Cashflow From Financing | - | 55.00 | - | - | - | - | - | - | - | -2,182 | -872 | - | -1* | 64,289 | -261* | -102 | 23,663 | 105 | - | - | - |
Buy Backs | - | - | - | - | - | - | -2,482 | 2,482 | 2,482 | 2,482 | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
General and administrative | $ 1,481,215 | $ 1,733,321 |
Research and development | 4,250,786 | 2,552,947 |
Total operating expenses | 5,732,001 | 4,286,268 |
Loss from operations | (5,732,001) | (4,286,268) |
Interest income | 200,950 | 133,782 |
Other income, net | 90,241 | 284,721 |
NET LOSS | $ (5,440,810) | $ (3,867,765) |
Net loss per share of common shares, basic | $ (0.51) | $ (0.36) |
Net loss per share of common shares, diluted | $ (0.51) | $ (0.36) |
Weighted-average number of common shares outstanding, basic | 10,742,797 | 10,857,040 |
Weighted-average number of common shares outstanding, diluted | 10,742,797 | 10,857,040 |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS | ||
Cash and cash equivalents | $ 18,357,944 | $ 21,937,749 |
Marketable securities | 19,999,910 | 19,364,923 |
Prepaid expenses & other current assets | 1,113,007 | 2,038,653 |
Total current assets | 39,470,861 | 43,341,325 |
Property and equipment, net | 50,283 | 52,127 |
Operating lease right-of-use assets | 187,211 | 228,295 |
Other assets | 25,869 | 25,869 |
TOTAL ASSETS | 39,734,224 | 43,647,616 |
CURRENT LIABILITIES | ||
Accounts payable and accrued expenses | 3,775,423 | 2,505,211 |
Operating lease liabilities, current | 178,023 | 172,975 |
Total current liabilities | 3,953,446 | 2,678,186 |
Operating lease liabilities, net of current portion | 15,561 | 61,496 |
TOTAL LIABILITIES | 3,969,007 | 2,739,682 |
COMMITMENTS AND CONTINGENCIES (NOTE 4) | ||
STOCKHOLDERS’ EQUITY | ||
Preferred Stock (1,000,000 authorized at March 31, 2024 and December 31, 2023; $.0001 par value) (Zero shares issued and outstanding at March 31, 2024 and December 31, 2023) | ||
Common Stock (25,000,000 authorized at March 31, 2024 and December 31, 2023; $.0001 par value) (10,758,805 shares and 10,721,192 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively) | 1,076 | 1,072 |
Additional paid-in capital | 96,447,495 | 96,258,726 |
Accumulated other comprehensive income (loss) | 1,860 | (107,460) |
Accumulated deficit | (60,685,214) | (55,244,404) |
Total stockholders’ equity | 35,765,217 | 40,907,934 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 39,734,224 | $ 43,647,616 |